IGBA’s 25th Annual Conference highlights the true value of the off-patent medicines industry for patients and health systems around the world (February 2023)
IGBA, the International Generic and Biosimilar medicines Association, representing global manufacturers of generic and biosimilar medicines, announced today that experts and leaders from the local and global generic and biosimilar medicines industries, Government and regulatory agencies, academia and other stakeholders are meeting from 15 to 16 February in Orlando, Florida to discuss key topics affecting worldwide patient access to affordable quality-assured medicines, such as...
